Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

The effectiveness of the BNT162b2 and ChAdOx1 vaccines against new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous re-evaluation, given the increasingly dominant B.1.617.2 (Delta) variant. In this study, we investigated the effectiveness of these vaccines...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Pouwels, KB, Pritchard, E, Matthews, PC, Stoesser, N, Eyre, DW, Vihta, K-D, House, T, Hay, J, Bell, JI, Newton, JN, Farrar, J, Crook, D, Cook, D, Rourke, E, Studley, R, Peto, TEA, Diamond, I, Walker, AS
Materialtyp: Journal article
Språk:English
Publicerad: Springer Nature 2021

Liknande verk

Liknande verk